PNV

0.00%

$2.30 polynovo limited

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

First 53 Last

Share
Profile

Follow
BPAA

4,202 Posts.

786

05/05/23

11:59

Post #: 67624800
Share

Originally posted by Hapman: ↑

Then you’ll probably be missing quite a few millions for not understanding your investment in pharmaceutical/medical shares.
Why is the SP being so heavily punished? Simple fact is growth hasn’t met market expectations. Why is this important is the simple fact that BTM/MTX only enjoy a very limited patented window. PNV needs to grow and establish its branding and product as fast as possible. Every quarter/month that it does not achieve such aggressive growth means we are closer and closer to when cheap Chinese/Indian generics will enter and/or large pharmaceuticals will enter with their massive deep pockets, large marketing and sales force and channels to disrupt a minnow like PNV. Essentially, the margin that you guys chirp about will shrink.
So unless PNV can quickly establishes itself as market leader, build up a large cash kitty (patent period) to be able to defend its market share.
sorry to burst your dreams but this is a tough tough market to be in and you either become the big fish or you get swallowed whole (Take over) or kicked out (lose market share and leave).
I believe my growth target is valid is more than fair. 60+%coming from existing staff (18mths+ service and based on Ed comment that 4 customer per sales to be driven up to 10+ and cross department reach within same hospital) and 20-50% from new staff added (6-18 mths service and gave them some discount based on some of the new hires might be only 6 mths into their jobs).
To simply look at the 50% growth and be satisfied is ignoring that PNV have had lots more foot solders on the ground to aid our course and organic sales growth from existing soldiers. No offence to kick’s model but maybe it needs to be updated to reflect that the company is a lot larger and it’s target needs to reflect this fact.

Expand

Writing a lot and hypothesizing doesn't make any of what you say correct. It probably feels good but its so far off anything logical

There is nothing to support what you're saying apart from your opinion

PNV Price at posting: $1.50 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

There are more pages in this discussion • 35 more messages in this thread...

First 53 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.30		Change 0.000(0.00%)		Mkt cap ! $1.587B

Open	High	Low	Value	Volume
$2.34	$2.35	$2.27	$1.711M	744.6K

Buyers (Bids)

No.	Vol.	Price($)
4	14000	$2.28

Sellers (Offers)

Price($)	Vol.	No.
$2.30	13896	5

View Market Depth

No.	Vol.	Price($)
1	2728	2.270
3	3789	2.260
10	20528	2.250
10	12281	2.240
4	105207	2.230

Price($)	Vol.	No.
2.310	3000	1
2.320	2728	1
2.330	11704	3
2.340	7728	2
2.350	30550	5

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PNV (ASX) Chart

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: PolyNovo presents at Macquarie Australia Conference, page-53

Top Stories

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Bitcoin investors need to know the risks

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

ASX hits all time high out the gate on Friday trades following bullish US inflation data

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Immutep reports strong response rate from immunotherapies treating carcinomas

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News